Cardiac macrophages in newborn mice promoted heart cell proliferation after injury, offering a potential approach to ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell suppression and reducing the frequency of metastases in mice models. This discovery suggests a ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

The scientists traced signals in the cell to determine that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). This was an unexpected revelation for ...

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.

The research team discovered that platelets release a substance called thromboxane A2 (TXA2), which attaches to receptors on ...

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking it daily without speaking to a doctor.

"New study shows aspirin may prevent cancer spread by enhancing immune system's ability to attack metastatic cells. Findings ...